# Characterization of Immune Semaphorin in Non Alcoholic Fatty Liver Disease and NASH

> **NCT02820285** · NA · COMPLETED · sponsor: **Centre Hospitalier Universitaire de Nice** · enrollment: 148 (actual)

## Conditions studied

- Non Alcoholic Fatty Liver Disease

## Interventions

- **OTHER:** Evaluation of the staging of fibrosis liver
- **OTHER:** Determine the expression level of semaphorin
- **OTHER:** Determination of the composition of immunity cells

## Key facts

- **NCT ID:** NCT02820285
- **Lead sponsor:** Centre Hospitalier Universitaire de Nice
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2016-09
- **Final completion:** 2016-09
- **Target enrollment:** 148 (ACTUAL)
- **Last updated:** 2026-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02820285

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02820285, "Characterization of Immune Semaphorin in Non Alcoholic Fatty Liver Disease and NASH". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT02820285. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*